FDA advisors to review COVID-19 shots for young kids, new boosters in October
The Peninsula
The U.S. Food and Drug Administration said an advisory panel of experts would hold meetings this month to discuss authorizing booster doses of Moderna Inc and Johnson & Johnson's COVID-19 vaccines, and clearing Pfizer's vaccine for use in children.
The panel will discuss authorizing Pfizer Inc's COVID-19 vaccine for children aged five through 11 on Oct. 26, the FDA said on Friday.
Last month, the FDA authorized a booster dose of the Pfizer and BioNTech vaccine for older adults and some Americans at high-risk of illness.
More Related News